Research

Teva and the IDF (2025)

This report describes some of the relationships between the pharmaceutical company Teva and the Israeli Defense Forces, with a special focus on the period since October 7th, 2023. Ethical questions are raised with regards to Teva’s role in Israel and Palestine, in light of the company’s robust support of the Israeli war effort.

Download report here.

Teva and the IDF. 2025
Teva and the IDF.

Captive Economy: The Pharmaceutical Industry and the Israeli Occupation (2012)

From the WhoProfits website:
“As a dominant part of the Israeli pharmaceutical industry, Teva enjoys the advantages generated by the Israeli occupation of Palestinian lands allowing the company to exploit the Palestinian market. ‘Quality and Security reasons’ in conjunction with economic and political justifications create a Palestinian captive market for Israeli and multinational companies.”

Download report here.

Report: Who Profits. 2011. Captive Economy.
Who Profits. Captive Economy.

KPMG: Teva Pharmaceutical Industries Ltd.: Targeted Research (2024)

This report, compiled by KPMG for a Norwegian hospital, details some of Teva’s activities in Palestine and the Occupied Territories.

Download report here.

KPMG: Teva Targeted Research. 2024
KPMG: Teva Targeted Research. 2024

Scroll to Top